Myeloid cell specific ablation of adenosine A2A receptor resulted in reduced melanoma tumor growth with significant increase in MHCII and IL-12 expression in TAMs with concomitant reduction of IL-10 expression in TAMs and MDCSs [58]. The gene discussed is IL10; the disease is neoplasm.